Publication date: Sep 06, 2024
The global emergence of -COVID-19 has prompted rapid therapeutic and vaccine advancements; however, clinical evidence remains limited. With around a 50% fatality rate for COVID-19 patients with acute respiratory distress syndrome (ARDS), early intervention is crucial. This report details a severe case of post-COVID-19 thrombocytopenia in a 79-year-old man and emphasizes its critical nature. Despite negative initial COVID-19 test results, subsequent positive results led to treatment initiation, and severe thrombocytopenia persisted resulting in bleeding complications and death. Recognized as a hematological manifestation of COVID-19, thrombocytopenia in this geriatric patient highlights the need for extended post-COVID-19 monitoring and management. This underscores the importance of vigilance and timely intervention, especially in vulnerable populations, and emphasizes the need for further research to understand the intricate relationship between COVID-19 and thrombocytopenia.
Concepts | Keywords |
---|---|
Covid | Clinical |
Early | Covid |
Thrombocytopenia | Emergence |
Vaccine | Emphasizes |
Geriatric | |
Global | |
Intervention | |
Partial | |
Patient | |
Post | |
Prompted | |
Rapid | |
Recovery | |
Severe | |
Thrombocytopenia |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | thrombocytopenia |
disease | MESH | COVID-19 |
disease | MESH | acute respiratory distress syndrome |
disease | IDO | intervention |
disease | MESH | bleeding |
disease | MESH | complications |
disease | MESH | death |
disease | MESH | Long Covid |